CELF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.647750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.736000E-01
Normal-vs-Stage2
1.959820E-01
Normal-vs-Stage3
8.535600E-02
Normal-vs-Stage4
9.279000E-01
Stage1-vs-Stage2
9.377600E-01
Stage1-vs-Stage3
1.840320E-02
Stage1-vs-Stage4
4.033600E-01
Stage2-vs-Stage3
3.234100E-02
Stage2-vs-Stage4
1.994800E-01
Stage3-vs-Stage4
6.739700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.782250E-01
Normal-vs-AfricanAmerican
3.841200E-01
Normal-vs-Asian
1.229590E-01
Caucasian-vs-AfricanAmerican
9.294000E-01
Caucasian-vs-Asian
1.404610E-01
AfricanAmerican-vs-Asian
3.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.198600E-01
Normal-vs-Female
1.277780E-01
Male-vs-Female
4.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.846800E-01
Normal-vs-Age(41-60Yrs)
4.138600E-01
Normal-vs-Age(61-80Yrs)
1.190450E-01
Normal-vs-Age(81-100Yrs)
6.118400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.494000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.114800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.988400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.521100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.720200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.917000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.387230E-01
Normal-vs-Daily Drinker
1.494380E-01
Normal-vs-Weekly Drinker
2.048200E-01
Normal-vs-Occasional Drinker
4.244800E-01
Normal-vs-Social Drinker
4.666800E-01
Non Drinker-vs-Daily Drinker
6.237400E-01
Non Drinker-vs-Weekly Drinker
8.249200E-01
Non Drinker-vs-Occasional Drinker
1.058750E-01
Non Drinker-vs-Social Drinker
9.751900E-02
Daily Drinker-vs-Weekly Drinker
8.553400E-01
Daily Drinker-vs-Occasional Drinker
7.024100E-02
Daily Drinker-vs-Social Drinker
6.929500E-02
Weekly Drinker-vs-Occasional Drinker
1.398410E-01
Weekly Drinker-vs-Social Drinker
1.308630E-01
Occasional Drinker-vs-Social Drinker
8.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.605600E-02
Normal-vs-Grade 2
1.295950E-03
Normal-vs-Grade 3
5.222200E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.319800E-02
Grade 1-vs-Grade 3
9.095700E-03
Grade 1-vs-Grade 4
4.605600E-02
Grade 2-vs-Grade 3
3.882000E-01
Grade 2-vs-Grade 4
1.295950E-03
Grade 3-vs-Grade 4
5.222200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.446800E-01
Normal-vs-NonDiabetic
1.393850E-01
Diabetic-vs-NonDiabetic
5.719800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.537800E-01
Normal-vs-NoPancreatitis
1.218980E-01
Pancreatitis-vs-NoPancreatitis
1.576780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.660410E-01
Normal-vs-N1
1.918000E-01
N0-vs-N1
5.739800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.868800E-01
Normal-vs-TP53-NonMutant
2.493200E-01
TP53-Mutant-vs-TP53-NonMutant
5.557800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
